We found that only the expression of IGFBP3 and SOCS2 was related to the clinical stage of HCC, and the expression of IGFBP3 increased with the increase of clinical stage, while the expression of SOCS2 decreased with the increase of the clinical stage (Figure 6A). This evidence concerns the gene IGFBP3 and hepatocellular carcinoma.